Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase 1 clinical and pharmacologic evaluation of treatment with high-dose melphalan in patients with colorectal cancer confined to the liver

A.L. Vahrmeijer; J.H. van Dierendonck; H.J. Keizer; J.H. Beijnen; R.A.E.M. Tollenaar; G.J. Mulder; C.J.H. van de Velde

Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase 1 clinical and pharmacologic evaluation of treatment with high-dose melphalan in patients with colorectal cancer confined to the liver

A.L. Vahrmeijer, J.H. van Dierendonck, H.J. Keizer, J.H. Beijnen, R.A.E.M. Tollenaar, G.J. Mulder, C.J.H. van de Velde

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1539-1546
Number of pages	8
Journal	British Journal of Cancer
Volume	82
Publication status	Published - 2000

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Vahrmeijer, A. L., van Dierendonck, J. H., Keizer, H. J., Beijnen, J. H., Tollenaar, R. A. E. M., Mulder, G. J., & van de Velde, C. J. H. (2000). Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase 1 clinical and pharmacologic evaluation of treatment with high-dose melphalan in patients with colorectal cancer confined to the liver. British Journal of Cancer, 82, 1539-1546.

@article{fe55513d5d5541a9b96ed3e7e3498e1e,

title = "Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase 1 clinical and pharmacologic evaluation of treatment with high-dose melphalan in patients with colorectal cancer confined to the liver",

author = "A.L. Vahrmeijer and {van Dierendonck}, J.H. and H.J. Keizer and J.H. Beijnen and R.A.E.M. Tollenaar and G.J. Mulder and {van de Velde}, C.J.H.",

year = "2000",

language = "Undefined/Unknown",

volume = "82",

pages = "1539--1546",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Springer Nature",

}

Vahrmeijer, AL, van Dierendonck, JH, Keizer, HJ, Beijnen, JH, Tollenaar, RAEM, Mulder, GJ & van de Velde, CJH 2000, 'Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase 1 clinical and pharmacologic evaluation of treatment with high-dose melphalan in patients with colorectal cancer confined to the liver', British Journal of Cancer, vol. 82, pp. 1539-1546.

Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase 1 clinical and pharmacologic evaluation of treatment with high-dose melphalan in patients with colorectal cancer confined to the liver. / Vahrmeijer, A.L.; van Dierendonck, J.H.; Keizer, H.J. et al.
In: British Journal of Cancer, Vol. 82, 2000, p. 1539-1546.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase 1 clinical and pharmacologic evaluation of treatment with high-dose melphalan in patients with colorectal cancer confined to the liver

AU - Vahrmeijer, A.L.

AU - van Dierendonck, J.H.

AU - Keizer, H.J.

AU - Beijnen, J.H.

AU - Tollenaar, R.A.E.M.

AU - Mulder, G.J.

AU - van de Velde, C.J.H.

PY - 2000

Y1 - 2000

M3 - Article

SN - 0007-0920

VL - 82

SP - 1539

EP - 1546

JO - British Journal of Cancer

JF - British Journal of Cancer

ER -